期刊文献+

SAP基因注射干预小鼠SLE样综合征的发生 被引量:1

SAP gene injection interfere the occurrence of murine SLE-like syndrome
下载PDF
导出
摘要 目的 :研究SAP基因注射对SLE发病的干预作用 ,并进一步探讨SAP发挥作用的可能机制。方法 :通过RT PCR方法克隆SAP基因 ,构建其真核表达质粒pcDNA3 SAP ,观察SAP基因注射对活化淋巴细胞免疫诱导小鼠产生的SLE样综合征的干预作用 ,以ELISA方法检测抗dsDNA抗体的产生情况 ,以免疫荧光法检测肾脏免疫复合物沉积 ;通过巨噬细胞吞噬实验观察SAP与DNA结合后对DNA清除的影响 ;用增殖实验检测巨噬细胞吞噬SAP结合的DNA后对预致敏淋巴细胞活化的影响。结果 :SAP基因注射可有效干预小鼠SLE样综合征的发生 ,SAP与活化淋巴细胞DNA结合后可明显促进巨噬细胞对DNA的吞噬 ,并且巨噬细胞吞噬SAP结合的DNA后不引起预致敏淋巴细胞的增殖。结论 Objective:To study the interference effect of the SAP gene injection on the SLE-like syndrome and to discuss its possible mechanism.Methods:The target DNA encoding SAP was cloned by RT-PCR, and its eukaryotic expression vector-pcDNA3-SAP was constructed, then observed the interference effect of the SAP gene injection on the SLE-like syndrome induced by activated lymphocytes immunization, the anti-dsDNA antibodies were detected by ELISA and immune complexes in glomeruli were observed by immunofluorescent stain. The clearance of DNA was observed by phagocytosis of macrophages and the proliferation assay was used to detect the influence of macrophages' ingesting SAP-binding DNA on the activation of primed lymphocytes.Results:SAP gene inoculation could interfere the occurrence of SLE-like syndrome, the binding of SAP to DNA from activated lymphocytes significantly promoted the uptake of DNA by macrophages, and macrophages that ingested the SAP-binding DNA would not cause the increased proliferation of primed lymphocytes. Conclusion:It suggested that SAP could interfere the occurrence of SLE through promoting the efficient clearance of autoantigenic DNA.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2004年第8期567-571,共5页 Chinese Journal of Immunology
基金 国家重点基础研究发展规划 ( 2 0 0 1CB5 10 0 0 6)资助项目
关键词 血清淀粉样P成分(SAP) DNA 系统性红斑狼疮 基因注射 Serum amyloid P component (SAP) DNA Systemic lupus erythematosus Gene injection
  • 相关文献

参考文献17

  • 1Tan E M, Von-Muhlen C A. Autoantibodies in the diagnosis of systemic rheumatic disease[J]. Semin Arthritis Rheum, 1995; 24(5): 323.
  • 2Pesetsky D S. The immunologic properties of DNA [J]. J Immunol,1996; 156: 421.
  • 3Pepys M B, Booth S E, Tennent G A et al . Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli[J]. Clin Exp Immunol, 1994; 9
  • 4Pepy M B. Serum amyloid P component control chromatin degradation and prevents antinuclear autoimmunity[J]. Nat Med, 1999; 5(6): 694.
  • 5Wu H S, Ma A N, Guo L. Active DNA or active histone triggering the production of antinuclear antibodies: inducing the generation of kidney iniury in mice[J]. J Allergy Clin Immunol, 2000; 105(1): s29.
  • 6Zhao X, Araki K, Miyazaki J et al . Developmental and liver-specific expression directed by the serum amyloid P component promoter in transgenic mice[J]. J Biochem (Tokyo), 1992; 111(6): 736.
  • 7Shephard E G, Smith P J, Coetzee S et al . Pentraxin binding to isolated rat liver nuclei[J]. Biochem J, 1991; 279 ( Pt 1):257.
  • 8Taylor P R, Carugati A, Fadok V A et al . A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo[J]. J Exp Med, 2000; 192:359.
  • 9Napirei M, Karsunky H, Zevnik B et al .Features of systemic lupus erythematosus in Dnasel-deficient mice[J]. Nat Genet,2000;25(2): 177.
  • 10马爱妞,吴厚生,张鹏.活性DNA诱导抗核抗体及系统性红斑狼疮样综合征[J].中华风湿病学杂志,2000,4(1):15-17. 被引量:11

二级参考文献14

  • 1夏金华,吴厚生.天然DNA和细胞因子对系统性红斑狼疮患者淋巴细胞体外分泌抗双链DNA抗体的影响[J].上海医科大学学报,1994,21(2):109-112. 被引量:13
  • 2钟叔平,温博贵,何开玲.SRS-淋巴瘤小鼠淋巴细胞染色质理化性质的研究[J].中国病理生理杂志,1994,10(4):378-382. 被引量:8
  • 3卢琳 李金柱.促丝裂原活化淋巴细胞诱导抗双链DNA抗体[J].上海医科大学学报,1997,25:250-250.
  • 4江泊 张亚历.分子生物学常用实验方法[M].北京:人民军医出版社,1996.65.
  • 5曹鹤年 马宝骊.组蛋白的纯化、鉴定及其抗核抗体检测的临床意义[J].上海免疫学杂志,1998,18:32-32.
  • 6夏金华,上海免疫学杂志,1993年,13卷,172页
  • 7Tan E M,Adv Immunol,1989年,44卷,93页
  • 8夏金华,上海医科大学学报,1993年,21卷,2期,109页
  • 9Tan E M,Adv Immunol,1989年,44卷,93页
  • 10江泊 张亚历 周殿元.分子生物学常用实验方法[M].北京:人民军医出版社,1996.65.

共引文献31

同被引文献7

  • 1Nauta A J, Daha MR, Kooten C, et al. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol,2003,24 : 148-154.
  • 2Sjowall C, Eriksson P, Almer S, et al. Autoantibodies to Creactive protein is a common finding in SLE, but not in primary Sjogren's syndrome,rheumatoid arthritis or inflammatory bowel disease. J Autoimmun,2002,19 : 155-160.
  • 3Du Clos TW. C-reactlve protein as a regulator of autoimmunity and inflammation. Arthritis Rheum,2003,48 : 1475-1477.
  • 4Gershov D, Kim S, Brot N, et al. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response : implications for systemic autoimmunlty.J Exp Med,2000 ,192 :1353-1364.
  • 5Sjowall C, Efiksson P, Almer S, et al. Autoantibodies to Creactive protein is a common finding in SLE, but not in primary Sjsgren's syndrome,rheumatoid arthritis or inflammatory bowel disease. J Autoimmun,2002,19:155-160.
  • 6Sanjeeb Kakati, B Doley, Pradip KS,et al. C-reactive protein in systemic lupus erythematosus.J India Rheumatol Assoc, 2003,11:66-70.
  • 7Alexander JS, Casey TW, Mark AM, et al. Delayed lupus onset in( NZB × NZW) F1 mice expression a Human C-reactive protein trangen.Arth Rheu, 2003,48 (6) : 1602-1611.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部